STOCK TITAN
  1. Home
  2. Sec-filings
  3. CALC
  4. [Form 4] CalciMedica, Inc. Insider Trading Activity

CalciMedica Executive Gets Major Stock Option Grant Following Plan Amendment

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Eric W. Roberts, Chief Business Officer, Director, and 10% Owner of CalciMedica, reported receiving a stock option grant for 72,750 shares of common stock. The option grant was initially approved by the Board on April 23, 2025, contingent on stockholder approval of amendments to the company's 2023 Equity Incentive Plan.

Key details of the stock option:

  • Exercise price: $1.53 per share
  • Grant date: June 24, 2025 (following stockholder approval)
  • Expiration date: April 22, 2035
  • Immediately exercisable upon grant
  • Direct ownership form

The transaction was reported via Form 4 filing, with the document signed by John Dunn as attorney-in-fact on June 26, 2025. This equity compensation grant aligns the executive's interests with those of shareholders through long-term stock ownership potential.

Positive

  • None.

Negative

  • None.
Insider Roberts Eric W
Role CHIEF BUSINESS OFFICER
Type Security Shares Price Value
Grant/Award Employee Stock Option (Right to Buy) 72,750 $0.00 --
Holdings After Transaction: Employee Stock Option (Right to Buy) — 72,750 shares (Direct)
Footnotes (1)
  1. The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025. Immediately exercisable.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Roberts Eric W
(Last) (First) (Middle)
C/O CALCIMEDICA, INC.
505 COAST BLVD. S. #307
(Street)
LA JOLLA CA 92037
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CalciMedica, Inc. [ CALC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CHIEF BUSINESS OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $1.53 06/24/2025(1) A 72,750 (2) 04/22/2035 Common Stock 72,750 $0 72,750 D
Explanation of Responses:
1. The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.
2. Immediately exercisable.
/s/ John Dunn, Attorney-in-Fact 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What stock options did CALC's Chief Business Officer Eric Roberts receive in June 2025?

Eric Roberts received 72,750 employee stock options with an exercise price of $1.53 per share. The options were granted on June 24, 2025, are immediately exercisable, and expire on April 22, 2035.

What positions does Eric Roberts hold at CalciMedica (CALC)?

Eric Roberts holds multiple positions at CalciMedica (CALC): he serves as the Chief Business Officer, Director, and is also a 10% owner of the company.

When was CALC's stock option grant to Eric Roberts originally approved?

The stock option grant was originally approved by CalciMedica's Board of Directors on April 23, 2025, but was subject to stockholder approval of an amendment to the company's 2023 Equity Incentive Plan, which was obtained on June 24, 2025.

What is the expiration date for Eric Roberts' CALC stock options granted in June 2025?

The stock options granted to Eric Roberts will expire on April 22, 2035, approximately 10 years from the original Board approval date.

Under which equity plan were CALC's stock options granted to Eric Roberts?

The stock options were granted under CalciMedica's Amended 2023 Equity Incentive Plan (the 'Amended 2023 EIP'), which received stockholder approval on June 24, 2025.